LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Biospecifics Technologies Corp.
Headquarters:
Lynbrook, NY, United States of America
Website:
N/A
Year Founded:
1990
Status:
Acquired
BioCentury
|
Oct 20, 2020
Deals
Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta
Genesis and Genentech collaborate to identify drug candidates using AIStanford spinout and AI platform company Genesis Therapeutics Inc. entered into a collaboration agreement with the
Read More
BioCentury
|
Jul 22, 2020
Management Tracks
Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more
Read More
BioCentury
|
May 14, 2020
Management Tracks
Jakob Dupont steps down as CMO of Gossamer; plus Ascendis, Seer, Jazz, Dragonfly and more
Read More
BioCentury
|
Apr 14, 2020
Management Tracks
Kelly joins CytoDyn as CMO amid COVID-19 trials; plus Antengene, Genetron, Bolt, BioSpecifics, CMAB and more
Read More
BioCentury
|
Apr 11, 2020
Management Tracks
Harpal Kumar named president of Grail Europe; plus Notable, Oncoceutics, ReAlta, Parker Institute
Read More
BioCentury
|
Apr 10, 2020
Management Tracks
Shakeup at Arix; plus Emergent, AlloVir, Asklepios Bio, Morphic, Gritstone and more
Read More
BioCentury
|
Oct 10, 2019
Company News
Management tracks: Galderma taps new leadership from Shire; plus iOmx, BioSpecifics, Poseida, Kedalion, GenSight, Lyra, Verrica and Mizuho
Read More
BioCentury
|
Apr 20, 2017
Clinical News
Xiaflex: Ph I started
Read More
BioCentury
|
Dec 1, 2016
Clinical News
Xiaflex: Ph IIa data
Read More
BioCentury
|
Feb 22, 2016
Clinical News
Xiaflex: Phase IIb started
Read More
Items per page:
10
1 - 10 of 205